Written by The Next-Generation Biomanufacturing Market is developing alongside the growing use of biological systems for manufacturing medicines, specialty chemicals, food ingredients, fuels, and sustainable materials. Companies are increasingly exploring biological production methods to improve resource efficiency and develop products that may be difficult to manufacture using conventional processes. The market is forecast to grow at a CAGR of 9.9% from 2025 to 2035.
Sustainability and digitalization are two major trends influencing the industry. Biomanufacturing can support the use of renewable resources and biodegradable materials, while automation and AI can help manufacturers monitor processes and identify opportunities for optimization. These technologies are also encouraging the development of more flexible production platforms capable of adapting to changing product requirements.
The market covers synthetic biology, cell-free systems, microbial biomanufacturing, and continuous bioprocessing. Microbial biomanufacturing held the largest technology share at 54% in 2024, while pharmaceuticals accounted for 52% of applications. The industrial end-use segment represented 58%, demonstrating the importance of commercial-scale production across healthcare, food, agriculture, and other industries.
North America accounted for more than 45% of global revenue in 2024, followed by Europe at approximately 30%. Asia-Pacific held around 20% and is becoming increasingly important as regional governments and companies invest in biotechnology and domestic manufacturing capabilities. Future opportunities include modular facilities, AI-based process optimization, personalized biomanufacturing, and sustainable production technologies.
Access detailed findings to navigate market complexities:
Digital Healthcare Market Volume
Digital Healthcare Market Forecast
Flow Cytometer Reagents Market Outlook